Evidence map›Paper›PMID 12206715›Full record

ArticleThe Biochemical journal2002

Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.

Koichi Saeki, Norihiko Kobayashi, Yuko Inazawa, Hong Zhang, Hideki Nishitoh, Hidenori Ichijo, Kumiko Saeki, Mamoru Isemura, Akira Yuo

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 131 citations in OpenAlex.

  1. Review
  2. The Effects of Green Tea Catechins in Hematological Malignancies.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Oxidative stress and potential applications of free radical scavengers in glaucoma.Redox report : communications in free radical research · 2013
    Review
  11. Article
  12. Health-promoting effects of green tea.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2012
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Koichi SaekiDepartment of Haematology, Research Institute, International Medical Centre of Japan, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
Norihiko Kobayashi
Yuko Inazawa
Hong Zhang
Hideki Nishitoh
Hidenori Ichijo
Kumiko Saeki
Mamoru Isemura
Akira Yuo
Saitama International Medical Center · JPTokyo Medical and Dental University · JPUniversity of Shizuoka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated intracellular signalling pathways for apoptosis induced by epigallocatechin-3-gallate (EGCG) as compared with those induced by a toxic chemical substance (etoposide, VP16) or the death receptor ligand [tumour necrosis factor (TNF)]. EGCG as well as VP16 and TNF induced activation of two apoptosis-regulating mitogen-activated protein (MAP) kinases, namely c-Jun N-terminal kinase (JNK) and p38 MAP kinase, in both human leukaemic U937 and OCI-AML1a cells. In U937 cells, the apoptosis and activation of caspases-3 and -9 induced by EGCG but not VP16 and TNF were inhibited with SB203580, a specific inhibitor of p38, while those induced by EGCG and VP16 but not TNF were inhibited with SB202190, a rather broad inhibitor of JNK and p38. In contrast, the EGCG-induced apoptosis in OCI-AML1a cells was resistant to SB203580 but not to SB202190. Unlike TNF, EGCG did not induce the activation of nuclear factor-kappaB but rather induced the primary activation of caspase-9. N -Acetyl-L-cysteine (NAC) almost completely abolished apoptosis induced by EGCG under conditions in which the apoptosis induced by VP16 or TNF was not affected. The JNK/p38 activation by EGCG was also potently inhibited by NAC, whereas those by VP16 and TNF were either not or only minimally affected by NAC. In addition, dithiothreitol also suppressed both apoptosis and JNK/p38 activation by EGCG, and EGCG-induced activation of MAP kinase kinase (MKK) 3/6, MKK4 and apoptosis-regulating kinase 1 (ASK1) was suppressed by NAC. Dominant negative ASK1, MKK6, MKK4 and JNK1 potently inhibited EGCG-induced cell death. EGCG induced an intracellular increase in reactive oxygen species and GSSG, both of which were also inhibited by NAC, and the decreased synthesis of glutathione rendered the cell susceptible to EGCG-induced apoptosis. Taken together these results strongly suggest that EGCG executed apoptotic cell death via an ASK1, MKK and JNK/p38 cascade which is triggered by NAC-sensitive intracellular oxidative events in a manner distinct from chemically induced or receptor-mediated apoptosis.

Indexed as

FlavonoidsAntioxidantsApoptosisBlotting, WesternCaspase 8Caspase 9CaspasesCatechinCell DeathDNA FragmentationDose-Response Relationship, DrugEnzyme ActivationEnzyme InhibitorsEtoposideFlow CytometryGlutathioneAntioxidantsCASP8 protein, humanCASP9 protein, humanCaspase 8Caspase 9CaspasesCatechinEnzyme Inhibitorsepigallocatechin gallateEtoposideFlavonoidsGlutathioneJNK Mitogen-Activated Protein KinasesMAP3K5 protein, humanMAP Kinase Kinase Kinase 5MAP Kinase Kinase KinasesMitogen-Activated Protein KinasesNF-kappa BNucleic Acid Synthesis InhibitorsOxygenp38 Mitogen-Activated Protein KinasesPhenolsPolymersReactive Oxygen SpeciesTumor Necrosis Factor-alphaUrokinase-Type Plasminogen Activator

Identifiers

PMID12206715
PMCPMC1223028
OpenAlexW2077233143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.